Inmazeb combines three antibodies The U.S. Food and Drug Administration approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies, as the first FDA-approved treatment for Zaire ebolavirus (Ebola virus) infection in adult and pediatric patients. “Today’s action demonstrates the FDA’s ongoing…
NBA players, staff already using saliva-based test extensively A saliva-based laboratory diagnostic test developed by researchers at the Yale School of Public Health to determine whether someone is infected with the novel coronavirus has been granted an emergency use authorization by the U.S. Food…
New evidence put forth at AAIC that vaacines might lower risk of Alzheimer’s For years, public health officials have been trying to dispel the myth that people who get a flu shot are more likely to get Alzheimer’s disease. Now those officials are armed…
Respiratory disorder taking on new focus during COVID-19 as researchers look into the causes of ARDS Researchers at the University of Illinois at Chicago have found that interleukin 1 beta, a protein known to activate immune responses, can disrupt signaling proteins, one of the…
AstraZeneca works to make Oxford vaccine available ASAP AstraZeneca (AZ) is advancing its response to address the unprecedented challenges of COVID-19, collaborating with numerous countries and organizations to make the University of Oxford’s vaccine widely accessible around the world in an equitable manner. AZ has…
Anakinra shows breathing improvements, but further study necessary A drug traditionally used in the treatment of arthritis, anakinra, may possess benefits in the treatment of severely ill COVID-19 patients, according to a new Italian study. Researchers found more than 70 percent of seriously ill…
University of Minnesota, Mayo Clinic combine to offer antibody test The University of Minnesota and Mayo Clinic may soon release an antibody test that can determine if people have already been infected by the coronavirus that caused COVID-19 and are no longer threats to…
FDA issued clinical trial guidance, though ‘Unavoidable’ protocol deviations are anticipated The U.S. Food and Drug Administration (FDA) issued clinical trial guidance last week for industry, investigators, and institutional review boards conducting clinical trials during the coronavirus (COVID-19) pandemic. The FDA recognizes that the COVID-19…
Agency providing ‘final guidance’ along pathway Last week, the FDA took significant action toward helping promote competition in the biologic market by providing final guidance on the pathway for “interchangeable” biologics, which may be substituted without the involvement of the prescriber, similar to how…
Activated clotting time (ACT) critical during major surgeries Investigators at the Medical College of Georgia and Augusta University Health have tested some common platforms that can quickly determine the speed of blood clotting, or activated clotting time (ACT) to allow them to act quickly…